Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2016
At a glance
- Drugs Aflibercept (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 26 May 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2017.
- 23 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 21 Jul 2014 New trial record